Senior insider sale
See Remarks at CRESCENT BIOPHARMA, INC. — senior position signals high conviction
$384.9K
21.35K shares
What this filing means
MCNEILL JONATHAN plans to sell 21.35K shares of CRESCENT BIOPHARMA, INC. valued at approximately $384.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/16/2026ACC: 0001628280-26-062213
Officer· See Remarks
Since Jun 2025
21.35K
Shares to sell
$384.9K
Approx. market value
1.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Services rendered
9/15/2026
1.59KTotal acquired1.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/15/2026 | Restricted Stock Unit Vesting Services rendered | 1.59K | — |
| Total | 1.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
20.55K
Market value
$369.8K
6/22/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
804.00
Market value
$15.1K
9/16/2026
Total
Units
21.35K
Value
$384.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/22/2026 | 20.55K | $369.8K | — | Completed |
| Planned — Approximate Date | ||||
9/16/2026 | 804.00 | $15.1K | Nasdaq | Planned |
| Total | 21.35K | $384.9K | ||